Sunil Healthcare Limited has published its unaudited financial results for the first quarter of the fiscal year 2026-27, which ended on June 30, 2026. The filing was submitted to the listing departments of both the Bombay Stock Exchange and the Calcutta Stock Exchange on August 15, 2026.

The disclosure was made pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. According to the filing, the financial results were published in the newspaper Pioneer on August 15, 2026, in both Hindi and English editions.

Filing Details

The submission was signed by Satyendu Pattnaik, the Company Secretary of Sunil Healthcare Limited. The document confirms that newspaper clippings of the published results were enclosed with the exchange filings as required by regulatory norms.

No specific financial figures, such as revenue, net profit, or EBITDA, were included in the text of the filing notice itself. Investors are directed to the published newspaper clipping or the company’s official disclosures for detailed financial data.

Sunil Healthcare Limited reported a consolidated net profit of ₹400.60 lakh for the financial year ended March 31, 2026, while its standalone results reflected a net loss of ₹530.21 lakh. The standalone performance was significantly impacted by exceptional items amounting to ₹958.25 lakh, primarily due to a provision for a foreign subsidiary and a fire incident at its Alwar plant. The company published the audited financial results for the quarter and year ended March 31, 2026, in the newspaper Pioneer on May 31, 2026, pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The company's consolidated revenue from operations for FY26 stood at ₹8,990.15 lakh, compared to ₹8,476.02 lakh in the previous year. On a standalone basis, revenue increased to ₹8,886.23 lakh from ₹8,477.28 lakh in FY25. The statutory auditors, M/s. Singhi & Co., Chartered Accountants, issued an unmodified opinion on the annual standalone and consolidated financial results.

Financial Performance

The divergence between standalone and consolidated profitability was driven by exceptional items recorded during the quarter ended March 31, 2026. The company reassessed the recoverability of outstanding balances from a foreign subsidiary, leading to a provision of ₹946.66 lakh. Additionally, a fire incident at the Alwar manufacturing plant resulted in damage to property, plant, and equipment with a carrying value of ₹355.95 lakh, which was written off. The company has recognized an insurance claim receivable of ₹344.35 lakh, expecting the loss to be fully recoverable.

Board Decisions

The Board of Directors met on May 29, 2026, to discuss the financial outcomes. In addition to approving the audited financial results, the Board appointed M/s. Agrawal S. Lal & Co., Chartered Accountants, as internal auditors for the financial year 2026-27. The Board also approved the Directors' Report for FY26.

The company's total assets as of March 31, 2026, stood at ₹16,232.00 lakh on a standalone basis and ₹16,450.55 lakh on a consolidated basis. The cash and cash equivalents at the end of the year were ₹6.53 lakh for the standalone entity and ₹7.39 lakh for the consolidated entity.